Efficacy News and Research

RSS
Cerulean initiates CRLX101 Phase 2 trial in non-small cell lung cancer

Cerulean initiates CRLX101 Phase 2 trial in non-small cell lung cancer

UIC to begin STX209 clinical trial for treatment of autism spectrum disorders

UIC to begin STX209 clinical trial for treatment of autism spectrum disorders

IGR, IPSEN sign 3 year medical oncology agreement

IGR, IPSEN sign 3 year medical oncology agreement

Groundbreaking study on treatment of separation anxiety disorder

Groundbreaking study on treatment of separation anxiety disorder

Molasses supplementation may reduce obesity in humans

Molasses supplementation may reduce obesity in humans

FDA approves protocol for Medtronic's SYMPLICITY HTN-3 for treatment of hypertension

FDA approves protocol for Medtronic's SYMPLICITY HTN-3 for treatment of hypertension

Enrollment complete in Advaxis ADXS-HPV Phase II CIN study

Enrollment complete in Advaxis ADXS-HPV Phase II CIN study

New method allows for concurrent treatment of spinal tumors and stabilization of the spine

New method allows for concurrent treatment of spinal tumors and stabilization of the spine

Potential causes for drops in children's immunization rate

Potential causes for drops in children's immunization rate

USANA receives FDA registration to manufacture OTC drugs

USANA receives FDA registration to manufacture OTC drugs

New radiofrequency ablation system for treating spinal tumors

New radiofrequency ablation system for treating spinal tumors

Positive top-line results from alemtuzumab Phase 3 trial on multiple sclerosis

Positive top-line results from alemtuzumab Phase 3 trial on multiple sclerosis

Scientists convert brain cells into cardiomyocytes

Scientists convert brain cells into cardiomyocytes

Top-line results from HyQ subcutaneous IG phase III study in patients with primary immunodeficiency

Top-line results from HyQ subcutaneous IG phase III study in patients with primary immunodeficiency

First dog enters ADXS-HER2 dose-ranging study in canine osteosarcoma

First dog enters ADXS-HER2 dose-ranging study in canine osteosarcoma

Study finds higher rate of switching from Byetta to Victoza in treatment of type 2 diabetes

Study finds higher rate of switching from Byetta to Victoza in treatment of type 2 diabetes

Scientists discover way to separate neural wheat from the chaff

Scientists discover way to separate neural wheat from the chaff

Researchers identify cellular origin of malignant glioma

Researchers identify cellular origin of malignant glioma

Enrollment commences in InterMune's Esbriet Phase 3 study for IPF

Enrollment commences in InterMune's Esbriet Phase 3 study for IPF

ThromboView gets positive results in study evaluating accuracy and safety

ThromboView gets positive results in study evaluating accuracy and safety

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.